NCT01635504View on ClinicalTrials.gov

HIV Posterior Cheek Enlargement

NACompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
HIV Posterior Cheek Enlargement
Interventions
BIOLOGICAL

Botulinum toxin A

Botulinum toxin A 50 units per side of the posterior cheek enlargement, injected into the masseter muscle and parotid gland (10 units into 5 points of the posterior cheek enlargement per side, giving a total of 100 units per patient)

Trial Locations (1)

V5Z 4E1

Carruthers Dermatology Center, Vancouver

All Listed Sponsors
lead

University of British Columbia

OTHER

NCT01635504 - HIV Posterior Cheek Enlargement | Biotech Hunter | Biotech Hunter